Press Releases

Agendia Expands Management Team to Meet Company Momentum, Appoints Brian Dow as Chief Financial Officer

Panthera’s UK oncology clinical trial sites open for studies

Panthera's UK oncology clinical trial sites are open despite 1000+ international cancer trials being suspended due to COVID-19.

CD Genomics Announces Advanced CDAMP® Panel Kits for SARS-CoV-2 Detection

CD Genomics Launches Complete Product Portfolio for Research to COVID-19 Response

Creative Enzymes Optimizes Screening of Enzyme Activators for Enzyme Profiling

Cell-Based Solutions for Tumor Research Are Available by Creative Proteomics’s Tumomics Platform

Creative Proteomics Introduces Advanced Gut Metatranscriptome Analysis Solutions

UK medtech firm awarded government grants to aid Covid-19 test development

UK medtech firm Bond Digital Health has received more than £200,000 in government grants to help it develop its connectivity and data platform for a new Covid-19 test. The Cardiff, Wales-based company was awarded two major grants in the space of a month for its innovative Transform technology - £177,979 from the Welsh Government and £49,796 from Innovate UK, the UK’s national innovation agency.

Creative Enzymes Optimizes Enzyme Stabilization and Formulation Services

Creative Proteomics Launches Untargeted Metabolomics Services for Drug Development

Elucid Digital Health’s dashboard gives pharma and CROs real time patient adherence data during a clinical trial

Elucid’s Pill Connect dispensing system provides CROs and pharma the ability to show adherence across the whole trial, by country, by site even down to the individual patient number in real time. The dashboard is automatically created by the dispensing of the pill/tablet through the intelligent Pill Connect cap which fits on any standard pill bottle. The patient receives a reminder on their phone when the pill or pills should be taken. The patient then touches the dispense button on the screen and the pill is ejected from the bottle and a signal is sent, via the phone, that the pill has been dispensed.

Quantabio’s UltraPlex 1-Step ToughMix Continues to Enhance CDC Protocols to Detect and Differentiate COVID-19 and Influenza Respiratory Diseases

Quantabio's UltraPlex 1-Step ToughMix was recognized as part of the new EUA for the CDC) Influenza SARS-CoV-2 (Flu SC2 Multiplex Assay.

VERICHEM LABORATORIES OFFERS FREE, CLIA COMPLIANT, WEB-BASED CALIBRATION VERIFICATION DATA REDUCTION SERVICES

VERICHEM LABORATORIES now offers all its customers free access to the company’s online, web-based, data reduction services that supports all necessary statistics required within the clinical laboratory to satisfy current CLIA and CAP requirements for the calibration verification of clinical assays.

Creative BioMart Updated Its Bacterial Expression Systems for Protein Expression Service

Creative Biostructure Released Cryo-EM for Gene Therapy

Profacgen Updated Its CLIP-Seq Service for RNA-Protein Interaction Study

Matexcel Enlarged Its Chitosan Products Offerings

Lifeasible Supports a Comprehensive Range of Environmental Tests

Creative Diagnostics Expands Response to COVID-19 to Recombinant SARS-CoV-2 RBD Mutants

The global cases of COVID-19 are expected to soar unceasingly, and to facilitate related research worldwide, Creative Diagnostics integrates recombinant SARS-CoV-2 RBD mutants to its SARS-CoV-2 products and services.

CD Bioparticles: A Trustworthy Provider of All Sorts of PEG Conjugations

As a top-class institution as well as experienced supplier in drug delivery, CD Bioparticles now launches cover-all PEG conjugations to global clients.